Sex Differences in Cardiovascular Disease Risk and Associated Risk Factors among People Living with HIV in China
By: Junwen Yu, Xiaoning Liu, Yun He, Zheng Zhu, Yuanyuan Xu, Changrong Yuan and Hongzhou Lu
References
- Ntsekhe M, Baker JV. Cardiovascular disease among persons living with HIV: New insights into pathogenesis and clinical manifestations in a global context. Circulation. 2023;147(1):83–100. DOI: 10.1161/CIRCULATIONAHA.122.057443
- Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. The Lancet. 2018;392(10148):685–697. DOI: 10.1016/S0140-6736(18)31311-4
- Shah A, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: Systematic review and meta-analysis. Circulation. 2018;138(11):1100–1112. DOI: 10.1161/CIRCULATIONAHA.117.033369
- Fragkou PC, Moschopoulos CD, Dimopoulou D, Triantafyllidi H, Birmpa D, Benas D, et al. Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives. Hellenic Journal of Cardiology. 2023;71:42–54. DOI: 10.1016/j.hjc.2022.12.013
- Silverberg MJ, Levine TM, Lea AN, Williams AE, Alexeeff SE, Bryant K, et al. Cardiovascular disease risk factor control in people with and without HIV. Clinical Infectious Diseases. 2024;78(5):1264–1271. DOI: 10.1093/cid/ciad728
- Hmiel L, Zhang S, Obare LM, Santana M, Wanjalla CN, Titanji BK, et al. Inflammatory and immune mechanisms for atherosclerotic cardiovascular disease in HIV. International Journal of Molecular Sciences. 2024;25(13):7266. DOI: 10.3390/ijms25137266
- Vos AG, Venter W. Cardiovascular toxicity of contemporary antiretroviral therapy. Current Opinion in HIV and AIDS. 2021;16(6):286–291. DOI: 10.1097/COH.0000000000000702
- Solomon D, Sabin CA, Mallon P, Winston A, Tariq S. Cardiovascular disease in women living with HIV: A narrative review. Maturitas. 2018;108:58–70. DOI: 10.1016/j.maturitas.2017.11.011
- Wise JM, Jackson EA, Kempf MC, Oates GR, Wang Z, Overton ET, et al. Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV. AIDS. 2023;37(11):1661–1669. DOI: 10.1097/QAD.0000000000003592
- Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Daskalakis D, Anastos K, et al. Sex- and poverty-specific patterns in cardiovascular disease mortality associated with human immunodeficiency virus, New York City, 2007–2017. Clinical Infectious Diseases. 2020;71(3):491–498. DOI: 10.1093/cid/ciz852
- Birabaharan M, Strunk A, Kaelber DC, Smith DM, Martin T. Sex differences in type 2 diabetes mellitus prevalence among persons with HIV. AIDS. 2022;36(3):383–389. DOI: 10.1097/QAD.0000000000003127
- Brañas F, Sánchez-Conde M, Carli F, Menozzi M, Raimondi A, Milic J, et al. Sex differences in people aging with HIV. Journal of Acquired Immune Deficiency Syndromes. 2020;83(3):284–291. DOI: 10.1097/QAI.0000000000002259
- Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation. 2014;129(25_suppl_2). DOI: 10.1161/01.cir.0000437741.48606.98
- Yu J, Liu X, Zhu Z, Yang Z, He J, Zhang L, et al. Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2023;10:1138234. DOI: 10.3389/fcvm.2023.1138234
- AIDS Professional Group Society Of Tropical Disease And Parasitology Of Chinese Medical Association. Chinese expert consensus on integrated lipid management in HIV/AIDS. Chinese Journal of Internal Medicine. 2023; 62(6):661–672. DOI: 10.3760/cma.j.cn112138-20230321-00165
- Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. International Journal of Cardiology. 2018;260:196–203. DOI: 10.1016/j.ijcard.2018.02.089
- Li X, Song X, Han Y, Qiu Z, Cao W, Li T. Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy. BMC Infectious Diseases. 2023;23(1):598. DOI: 10.1186/s12879-023-08587-0
- Padmapriyadarsini C, Ramesh K, Sekar L, Ramachandran G, Reddy D, Narendran G, et al. Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy. Indian Journal of Medical Research. 2017;145(5):641–650. DOI: 10.4103/ijmr.IJMR_1611_15
- Papantoniou E, Arvanitakis K, Markakis K, Papadakos SP, Tsachouridou O, Popovic DS, et al. Pathophysiology and clinical management of dyslipidemia in people living with HIV: Sailing through rough seas. Life. 2024;14(4):449. DOI: 10.3390/life14040449
- Zhou DT, Nehumba D, Oktedalen O, Marange P, Kodogo V, Gomo ZA, et al. Changes in lipid profiles of HIV(+) adults over nine months at a Harare HIV clinic: A longitudinal study. Biochemistry Research International. 2016;2016(1):3204818. DOI: 10.1155/2016/3204818
- Hamooya BM, Musonda P, Mutale W, Masenga SK, Halwiindi H, Mutengo KH, et al. Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings. PLoS One. 2021;16(2):
e0247004 . DOI: 10.1371/journal.pone.0247004 - Ombeni W, Kamuhabwa AR. Lipid profile in HIV-infected patients using first-line antiretroviral drugs. Journal of the International Association of Providers of AIDS Care. 2016;15(2):164–171. DOI: 10.1177/2325957415614642
- Barton M. Cholesterol and atherosclerosis: Modulation by oestrogen. Current Opinion in Lipidology. 2013;24(3):214–220. DOI: 10.1097/MOL.0b013e3283613a94
- Ding M, Manson JE. HDL-c and arterial calcification in midlife women: Does an HDL paradox exist? Menopause. 2021;28(3):231–233. DOI: 10.1097/GME.0000000000001721
- Man JJ, Beckman JA, Jaffe IZ. Sex as a biological variable in atherosclerosis. Circulation Research. 2020;126(9):1297–1319. DOI: 10.1161/CIRCRESAHA.120.315930
- Holven KB, Roeters Van Lennep J. Sex differences in lipids: A life course approach. Atherosclerosis. 2023;384:117270. DOI: 10.1016/j.atherosclerosis.2023.117270
- Barrea L, Verde L, Suárez R, Frias-Toral E, Vásquez CA, Colao A, et al. Sex-differences in Mediterranean diet: a key piece to explain sex-related cardiovascular risk in obesity? A cross-sectional study. Journal of Translational Medicine. 2024;22(1):44. DOI: 10.1186/s12967-023-04814-z
- Liu J, Hou Y, Sun L, Wang L, He Y, Zhou Y, et al. High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: A cohort study. Emerging Microbes & Infections. 2021;10(1):416–423. DOI: 10.1080/22221751.2021.1894904
- Rajendran A, Minhas AS, Kazzi B, Varma B, Choi E, Thakkar A, et al. Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women. Atherosclerosis. 2023;384:117269. DOI: 10.1016/j.atherosclerosis.2023.117269
- Torosyan N, Visrodia P, Torbati T, Minissian MB, Shufelt CL. Dyslipidemia in midlife women: Approach and considerations during the menopausal transition. Maturitas. 2022;166:14–20. DOI: 10.1016/j.maturitas.2022.08.001
- Tabassum R, Widén E, Ripatti S. Effect of biological sex on human circulating lipidome: An overview of the literature. Atherosclerosis. 2023;384:117274. DOI: 10.1016/j.atherosclerosis.2023.117274
- Woodward M. Cardiovascular disease and the female disadvantage. International Journal of Environmental Research and Public Health. 2019;16(7):1165. DOI: 10.3390/ijerph16071165
DOI: https://doi.org/10.5334/gh.1553 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 21, 2025
Accepted on: Apr 15, 2026
Published on: Apr 24, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2026 Junwen Yu, Xiaoning Liu, Yun He, Zheng Zhu, Yuanyuan Xu, Changrong Yuan, Hongzhou Lu, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.